Enlivex Therapeutics Ltd. Quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Enlivex Therapeutics Ltd. quarterly Operating Lease, Weighted Average Discount Rate, Percent history and growth rate from Q4 2019 to Q2 2024.
  • Enlivex Therapeutics Ltd. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending June 30, 2024 was 0.07 pure, a 88.2% increase year-over-year.
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 0.07 +0.03 +88.2% Jun 30, 2024 6-K 2024-08-30
Q4 2023 0.07 +0.03 +88.2% Dec 31, 2023 6-K 2024-08-30
Q2 2023 0.03 0 0% Jun 30, 2023 6-K 2023-09-01
Q4 2022 0.03 0 0% Dec 31, 2022 20-F 2024-04-30
Q2 2022 0.04 -0.08 -67.2% Jun 30, 2022 6-K 2022-08-22
Q4 2021 0.04 -0.08 -67.2% Dec 31, 2021 20-F 2023-04-10
Q2 2021 0.12 +0.01 +9.35% Jun 30, 2021 6-K 2021-08-06
Q4 2020 0.12 +0.01 +9.35% Dec 31, 2020 20-F 2022-04-29
Q2 2020 0.11 Jun 30, 2020 6-K/A 2020-10-13
Q4 2019 0.11 Dec 31, 2019 20-F 2021-04-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.